ResearcherSeoul National UniversityActive in the last 2 years
Dong‐Won Ahn
Matched on ORCID iD 0000-0002-6641-2177; OpenAlex author ID A5048392267, A5102225896, A5104036135. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic Adenocarcinoma: A Prospective Multicente… Co-author DOI 10.1093/clinchem/hvaf066↗
- Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer. First author DOI 10.21037/jgo-22-218↗
- Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancreatic cancer. Co-author DOI 10.1016/j.hbpd.2020.05.005↗
- Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318249d62e↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jin‐Hyeok Hwang · 3 shared papers, 2012–2025 · strength 0.41
- Paper Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic … DOI 10.1093/clinchem/hvaf066↗
- Paper Association between progression-free survival and metal stent patency in patients with advanced pancreatic cancer. DOI 10.21037/jgo-22-218↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Sang Hyub Lee · 3 shared papers, 2012–2025 · strength 0.37
- Paper Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic … DOI 10.1093/clinchem/hvaf066↗
- Paper Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancr… DOI 10.1016/j.hbpd.2020.05.005↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Eui Joo Kim · 1 shared paper, 2025 · strength 0.22
- Sung‐Sik Han · 1 shared paper, 2025 · strength 0.22
- Min Kyu Jung · 1 shared paper, 2025 · strength 0.22
- Min Kyeong Kim · 1 shared paper, 2025 · strength 0.22
- Jung Won Chun · 1 shared paper, 2025 · strength 0.22
- Woo Jin Lee · 1 shared paper, 2025 · strength 0.22
- Sang‐Jae Park · 1 shared paper, 2025 · strength 0.22
- Sun‐Young Kong · 1 shared paper, 2025 · strength 0.22
- Yun‐Hee Kim · 1 shared paper, 2025 · strength 0.22
- Sang Myung Woo · 1 shared paper, 2025 · strength 0.22
- Jinwoo Ahn · 1 shared paper, 2022 · strength 0.16
- Jong-Chan Lee · 1 shared paper, 2022 · strength 0.16
- Kwangrok Jung · 1 shared paper, 2022 · strength 0.16
- Jaihwan Kim · 1 shared paper, 2022 · strength 0.16
- Ji Kon Ryu · 2 shared papers, 2012–2020 · strength 0.15
- Paper Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancr… DOI 10.1016/j.hbpd.2020.05.005↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Yong‐Tae Kim · 2 shared papers, 2012–2020 · strength 0.15
- Paper Folfirinox chemotherapy prolongs stent patency in patients with malignant biliary obstruction due to unresectable pancr… DOI 10.1016/j.hbpd.2020.05.005↗
- Paper Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. DOI 10.1097/mpa.0b013e318249d62e↗
- Woo Hyun Paik · 1 shared paper, 2020 · strength 0.12
- Jinwoo Kang · 1 shared paper, 2020 · strength 0.12
- Jin Ho Choi · 1 shared paper, 2020 · strength 0.12
- Jun Kyu Lee · 1 shared paper, 2012 · strength 0.03
- Yong Bum Yoon · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.